N.F.U. Mutual Unit Managers Ltd’s Vertex Pharmaceuticals VRTX Stock Holding History

N.F.U. Mutual Unit Managers Ltd’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$999K	Buy	+1,910	New	+$978K	0.18%	132

Other funds holding VRTX

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

N.F.U. Mutual Unit Managers Ltd's VRTX Position: Q3 2026 in Review

N.F.U. Mutual Unit Managers Ltd opened a new position in Vertex Pharmaceuticals (VRTX) in Q3 2026: 1,910 shares worth $999K. The stake represents 0.18% of the portfolio and ranks #132 among its holdings.

1,556 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

N.F.U. Mutual Unit Managers Ltd held 1,910 shares of Vertex Pharmaceuticals worth $999K as of Q3 2026.
Vertex Pharmaceuticals was a new N.F.U. Mutual Unit Managers Ltd position in Q3 2026.
Vertex Pharmaceuticals made up 0.18% of N.F.U. Mutual Unit Managers Ltd's portfolio in Q3 2026, its #132 holding.
1,556 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on N.F.U. Mutual Unit Managers Ltd's 13F filing for Q3 2026, filed 12 Nov 2026.